JORDAN KOONTZ: Open Payments
NPI 1255824686 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 136 payments from 13 companies in 2025. Trend: 2023 $1,362 · 2024 $2,190 · 2025 $2,514
Food & beverage: $2,375Education: $139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $530 |
| Otsuka America Pharmaceutical, Inc. | 20 | $370 |
| Teva Pharmaceuticals USA, Inc. | 15 | $356 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $337 |
| Janssen Pharmaceuticals, Inc | 20 | $312 |
| Alkermes, Inc. | 11 | $242 |
| E.R. Squibb & Sons, L.L.C. | 8 | $144 |
| Lundbeck LLC | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $48 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, INVEGA SUSTENNA, UZEDY, COBENFY, SPRAVATO.
Industry payments across PA — which companies pay providers there.
